Chin Cecilia L, Manzel Lori J, Lehman Erin E, Humlicek Alicia L, Shi Lei, Starner Timothy D, Denning Gerene M, Murphy Timothy F, Sethi Sanjay, Look Dwight C
Department of Internal Medicine, University of Iowa Carver College of Medicine, 200 Hawkins Drive, C33-GH, Iowa City, IA 52242, USA.
Am J Respir Crit Care Med. 2005 Jul 1;172(1):85-91. doi: 10.1164/rccm.200412-1687OC. Epub 2005 Apr 1.
Airway infection with Haemophilus influenzae causes airway inflammation, and isolation of new strains of this bacteria is associated with increased risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD).
To determine whether strains of H. influenzae associated with exacerbations cause more inflammation than strains that colonize the airways of patients with COPD.
Exacerbation strains of H. influenzae were isolated from patients during exacerbation of clinical symptoms with subsequent development of a homologous serum antibody response and were compared with colonization strains that were not associated with symptom worsening or an antibody response. Bacterial strains were compared using an in vivo mouse model of airway infection and in vitro cell culture model of bacterial adherence and defense gene and signaling pathway activation in primary human airway epithelial cells.
H. influenzae associated with exacerbations caused more airway neutrophil recruitment compared with colonization strains in the mouse model of airway bacterial infection. Furthermore, exacerbation strains adhered to epithelial cells in significantly higher numbers and induced more interleukin-8 release after interaction with airway epithelial cells. This effect was likely mediated by increased activation of the nuclear factor-kappaB and p38 mitogen-activated protein kinase signaling pathways.
The results indicate that H. influenzae strains isolated from patients during COPD exacerbations often induce more airway inflammation and likely have differences in virulence compared with colonizing strains. These findings support the concept that bacteria infecting the airway during COPD exacerbations mediate increased airway inflammation and contribute to decreased airway function.
流感嗜血杆菌引起的气道感染会导致气道炎症,分离出这种细菌的新菌株与慢性阻塞性肺疾病(COPD)患者病情加重的风险增加有关。
确定与病情加重相关的流感嗜血杆菌菌株是否比定植于COPD患者气道的菌株引起更多炎症。
在临床症状加重期间从患者中分离出流感嗜血杆菌的病情加重菌株,随后产生同源血清抗体反应,并与不伴有症状恶化或抗体反应的定植菌株进行比较。使用气道感染的体内小鼠模型以及原代人气道上皮细胞中细菌黏附、防御基因和信号通路激活的体外细胞培养模型对细菌菌株进行比较。
在气道细菌感染的小鼠模型中,与定植菌株相比,与病情加重相关的流感嗜血杆菌引起更多的气道中性粒细胞募集。此外,病情加重菌株与气道上皮细胞相互作用后,黏附于上皮细胞的数量明显更多,并诱导更多白细胞介素-8释放。这种效应可能是由核因子-κB和p38丝裂原活化蛋白激酶信号通路的激活增加介导的。
结果表明,在COPD病情加重期间从患者中分离出的流感嗜血杆菌菌株通常会诱导更多的气道炎症,与定植菌株相比,其毒力可能存在差异。这些发现支持了这样的概念,即COPD病情加重期间感染气道的细菌介导气道炎症增加,并导致气道功能下降。